nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—CDCA7—type 1 diabetes mellitus	0.0371	0.119	CbGpPWpGaD
Gabapentin—CACNA1B—Synaptic Vesicle Pathway—SLC18A2—type 1 diabetes mellitus	0.0172	0.0555	CbGpPWpGaD
Gabapentin—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.0167	0.0273	CcSEcCtD
Gabapentin—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.0165	0.0269	CcSEcCtD
Gabapentin—ADORA1—nerve—type 1 diabetes mellitus	0.0164	0.213	CbGeAlD
Gabapentin—Balance disorder—Ramipril—type 1 diabetes mellitus	0.015	0.0245	CcSEcCtD
Gabapentin—Psoriasis—Ramipril—type 1 diabetes mellitus	0.013	0.0213	CcSEcCtD
Gabapentin—BCAT1—islet of Langerhans—type 1 diabetes mellitus	0.0125	0.162	CbGeAlD
Gabapentin—CACNA2D2—islet of Langerhans—type 1 diabetes mellitus	0.0115	0.148	CbGeAlD
Gabapentin—CACNA2D2—Regulation of insulin secretion—ABCC8—type 1 diabetes mellitus	0.0107	0.0346	CbGpPWpGaD
Gabapentin—BCAT1—retina—type 1 diabetes mellitus	0.0107	0.138	CbGeAlD
Gabapentin—Ageusia—Ramipril—type 1 diabetes mellitus	0.0101	0.0165	CcSEcCtD
Gabapentin—Cough increased—Ramipril—type 1 diabetes mellitus	0.00895	0.0146	CcSEcCtD
Gabapentin—Glossitis—Ramipril—type 1 diabetes mellitus	0.00889	0.0145	CcSEcCtD
Gabapentin—Drug interaction—Ramipril—type 1 diabetes mellitus	0.00883	0.0144	CcSEcCtD
Gabapentin—BCAT1—pancreas—type 1 diabetes mellitus	0.0088	0.114	CbGeAlD
Gabapentin—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00861	0.0141	CcSEcCtD
Gabapentin—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00861	0.0141	CcSEcCtD
Gabapentin—CACNA2D2—Regulation of insulin secretion—KCNJ11—type 1 diabetes mellitus	0.00849	0.0273	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—ABCC8—type 1 diabetes mellitus	0.00844	0.0272	CbGpPWpGaD
Gabapentin—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00796	0.013	CcSEcCtD
Gabapentin—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00769	0.0126	CcSEcCtD
Gabapentin—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00745	0.0122	CcSEcCtD
Gabapentin—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00741	0.0121	CcSEcCtD
Gabapentin—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00733	0.012	CcSEcCtD
Gabapentin—CACNA2D2—Regulation of insulin secretion—ITPR3—type 1 diabetes mellitus	0.00716	0.0231	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—CHRM2—type 1 diabetes mellitus	0.0071	0.0229	CbGpPWpGaD
Gabapentin—Polyuria—Ramipril—type 1 diabetes mellitus	0.00677	0.0111	CcSEcCtD
Gabapentin—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00671	0.011	CcSEcCtD
Gabapentin—CACNA2D2—Integration of energy metabolism—KCNJ11—type 1 diabetes mellitus	0.00667	0.0215	CbGpPWpGaD
Gabapentin—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00665	0.0109	CcSEcCtD
Gabapentin—Deafness—Ramipril—type 1 diabetes mellitus	0.00665	0.0109	CcSEcCtD
Gabapentin—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00662	0.0108	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.0066	0.0213	CbGpPWpGaD
Gabapentin—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00644	0.0105	CcSEcCtD
Gabapentin—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00641	0.0105	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ITPR3—type 1 diabetes mellitus	0.00638	0.0205	CbGpPWpGaD
Gabapentin—Amnesia—Ramipril—type 1 diabetes mellitus	0.00633	0.0103	CcSEcCtD
Gabapentin—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00627	0.0102	CcSEcCtD
Gabapentin—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00625	0.0102	CcSEcCtD
Gabapentin—Purpura—Ramipril—type 1 diabetes mellitus	0.00617	0.0101	CcSEcCtD
Gabapentin—Arthritis—Ramipril—type 1 diabetes mellitus	0.00612	0.00999	CcSEcCtD
Gabapentin—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00609	0.00995	CcSEcCtD
Gabapentin—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00609	0.00995	CcSEcCtD
Gabapentin—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00607	0.00991	CcSEcCtD
Gabapentin—CACNA2D1—cardiovascular system—type 1 diabetes mellitus	0.00597	0.0772	CbGeAlD
Gabapentin—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00597	0.00975	CcSEcCtD
Gabapentin—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.0059	0.00964	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00579	0.0186	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00578	0.0186	CbGpPWpGaD
Gabapentin—ADORA1—cardiovascular system—type 1 diabetes mellitus	0.00576	0.0745	CbGeAlD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.00572	0.0184	CbGpPWpGaD
Gabapentin—ADORA1—kidney—type 1 diabetes mellitus	0.00564	0.0729	CbGeAlD
Gabapentin—CACNA2D2—Integration of energy metabolism—ITPR3—type 1 diabetes mellitus	0.00563	0.0181	CbGpPWpGaD
Gabapentin—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00557	0.0091	CcSEcCtD
Gabapentin—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00549	0.00897	CcSEcCtD
Gabapentin—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00537	0.00878	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—CDK4—type 1 diabetes mellitus	0.00535	0.0172	CbGpPWpGaD
Gabapentin—Gastritis—Ramipril—type 1 diabetes mellitus	0.00526	0.0086	CcSEcCtD
Gabapentin—CACNA2D2—Regulation of insulin secretion—GCG—type 1 diabetes mellitus	0.00524	0.0169	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ADRB1—type 1 diabetes mellitus	0.00521	0.0168	CbGpPWpGaD
Gabapentin—Asthma—Ramipril—type 1 diabetes mellitus	0.00514	0.00839	CcSEcCtD
Gabapentin—Influenza—Ramipril—type 1 diabetes mellitus	0.00514	0.00839	CcSEcCtD
Gabapentin—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00514	0.00839	CcSEcCtD
Gabapentin—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00509	0.00831	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—GAD2—type 1 diabetes mellitus	0.00506	0.0163	CbGpPWpGaD
Gabapentin—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00505	0.00826	CcSEcCtD
Gabapentin—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00504	0.00823	CcSEcCtD
Gabapentin—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00501	0.00818	CcSEcCtD
Gabapentin—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00501	0.00818	CcSEcCtD
Gabapentin—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00494	0.00807	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00478	0.0078	CcSEcCtD
Gabapentin—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00473	0.00773	CcSEcCtD
Gabapentin—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00469	0.00766	CcSEcCtD
Gabapentin—Weight increased—Ramipril—type 1 diabetes mellitus	0.00468	0.00764	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.00457	0.0147	CbGpPWpGaD
Gabapentin—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00454	0.00742	CcSEcCtD
Gabapentin—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00452	0.00738	CcSEcCtD
Gabapentin—Renal failure—Ramipril—type 1 diabetes mellitus	0.0045	0.00736	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—PRKCQ—type 1 diabetes mellitus	0.00449	0.0145	CbGpPWpGaD
Gabapentin—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00449	0.00734	CcSEcCtD
Gabapentin—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00449	0.00734	CcSEcCtD
Gabapentin—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00447	0.0073	CcSEcCtD
Gabapentin—Jaundice—Ramipril—type 1 diabetes mellitus	0.00447	0.0073	CcSEcCtD
Gabapentin—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00445	0.00728	CcSEcCtD
Gabapentin—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00445	0.00728	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00443	0.0143	CbGpPWpGaD
Gabapentin—Sweating—Ramipril—type 1 diabetes mellitus	0.00439	0.00718	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—GAD1—type 1 diabetes mellitus	0.00438	0.0141	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.00437	0.0141	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PAX4—type 1 diabetes mellitus	0.00434	0.014	CbGpPWpGaD
Gabapentin—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00433	0.00708	CcSEcCtD
Gabapentin—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00432	0.00706	CcSEcCtD
Gabapentin—Sinusitis—Ramipril—type 1 diabetes mellitus	0.0043	0.00702	CcSEcCtD
Gabapentin—CACNA2D2—Integration of energy metabolism—GCG—type 1 diabetes mellitus	0.00412	0.0133	CbGpPWpGaD
Gabapentin—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00411	0.00672	CcSEcCtD
Gabapentin—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00405	0.00662	CcSEcCtD
Gabapentin—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00404	0.0066	CcSEcCtD
Gabapentin—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00396	0.00648	CcSEcCtD
Gabapentin—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00389	0.00635	CcSEcCtD
Gabapentin—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00384	0.00627	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00383	0.0123	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00383	0.0123	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.00379	0.0122	CbGpPWpGaD
Gabapentin—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00372	0.00607	CcSEcCtD
Gabapentin—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00371	0.00606	CcSEcCtD
Gabapentin—Alopecia—Ramipril—type 1 diabetes mellitus	0.00363	0.00594	CcSEcCtD
Gabapentin—Mental disorder—Ramipril—type 1 diabetes mellitus	0.0036	0.00589	CcSEcCtD
Gabapentin—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00358	0.00585	CcSEcCtD
Gabapentin—Erythema—Ramipril—type 1 diabetes mellitus	0.00358	0.00585	CcSEcCtD
Gabapentin—Tension—Ramipril—type 1 diabetes mellitus	0.00351	0.00574	CcSEcCtD
Gabapentin—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00351	0.00573	CcSEcCtD
Gabapentin—Nervousness—Ramipril—type 1 diabetes mellitus	0.00348	0.00568	CcSEcCtD
Gabapentin—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00344	0.00562	CcSEcCtD
Gabapentin—Tremor—Ramipril—type 1 diabetes mellitus	0.00335	0.00548	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—GAD2—type 1 diabetes mellitus	0.00335	0.0108	CbGpPWpGaD
Gabapentin—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00332	0.00543	CcSEcCtD
Gabapentin—Agitation—Ramipril—type 1 diabetes mellitus	0.00329	0.00538	CcSEcCtD
Gabapentin—Angioedema—Ramipril—type 1 diabetes mellitus	0.00327	0.00534	CcSEcCtD
Gabapentin—Malaise—Ramipril—type 1 diabetes mellitus	0.00323	0.00527	CcSEcCtD
Gabapentin—Vertigo—Ramipril—type 1 diabetes mellitus	0.00322	0.00526	CcSEcCtD
Gabapentin—Syncope—Ramipril—type 1 diabetes mellitus	0.00321	0.00525	CcSEcCtD
Gabapentin—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00321	0.00524	CcSEcCtD
Gabapentin—Palpitations—Ramipril—type 1 diabetes mellitus	0.00316	0.00517	CcSEcCtD
Gabapentin—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00315	0.00514	CcSEcCtD
Gabapentin—Cough—Ramipril—type 1 diabetes mellitus	0.00312	0.0051	CcSEcCtD
Gabapentin—Convulsion—Ramipril—type 1 diabetes mellitus	0.0031	0.00507	CcSEcCtD
Gabapentin—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00305	0.00498	CcSEcCtD
Gabapentin—Chest pain—Ramipril—type 1 diabetes mellitus	0.00305	0.00498	CcSEcCtD
Gabapentin—Myalgia—Ramipril—type 1 diabetes mellitus	0.00305	0.00498	CcSEcCtD
Gabapentin—Anxiety—Ramipril—type 1 diabetes mellitus	0.00304	0.00496	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.00303	0.00976	CbGpPWpGaD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00303	0.00495	CcSEcCtD
Gabapentin—Discomfort—Ramipril—type 1 diabetes mellitus	0.00301	0.00492	CcSEcCtD
Gabapentin—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00298	0.00487	CcSEcCtD
Gabapentin—Confusional state—Ramipril—type 1 diabetes mellitus	0.00295	0.00481	CcSEcCtD
Gabapentin—CACNA2D2—Regulation of insulin secretion—INS—type 1 diabetes mellitus	0.00295	0.00949	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00293	0.00945	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PRF1—type 1 diabetes mellitus	0.00293	0.00943	CbGpPWpGaD
Gabapentin—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00292	0.00477	CcSEcCtD
Gabapentin—Oedema—Ramipril—type 1 diabetes mellitus	0.00292	0.00477	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—GAD1—type 1 diabetes mellitus	0.0029	0.00935	CbGpPWpGaD
Gabapentin—Shock—Ramipril—type 1 diabetes mellitus	0.00288	0.0047	CcSEcCtD
Gabapentin—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00287	0.00468	CcSEcCtD
Gabapentin—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00286	0.00467	CcSEcCtD
Gabapentin—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00285	0.00466	CcSEcCtD
Gabapentin—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00284	0.00464	CcSEcCtD
Gabapentin—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00283	0.00462	CcSEcCtD
Gabapentin—Anorexia—Ramipril—type 1 diabetes mellitus	0.00279	0.00455	CcSEcCtD
Gabapentin—Hypotension—Ramipril—type 1 diabetes mellitus	0.00273	0.00446	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00266	0.00435	CcSEcCtD
Gabapentin—Insomnia—Ramipril—type 1 diabetes mellitus	0.00264	0.00432	CcSEcCtD
Gabapentin—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00262	0.00429	CcSEcCtD
Gabapentin—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00261	0.00426	CcSEcCtD
Gabapentin—Somnolence—Ramipril—type 1 diabetes mellitus	0.0026	0.00424	CcSEcCtD
Gabapentin—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00257	0.0042	CcSEcCtD
Gabapentin—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00254	0.00415	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00252	0.00412	CcSEcCtD
Gabapentin—Fatigue—Ramipril—type 1 diabetes mellitus	0.00252	0.00412	CcSEcCtD
Gabapentin—Constipation—Ramipril—type 1 diabetes mellitus	0.0025	0.00408	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—GAL—type 1 diabetes mellitus	0.00249	0.00803	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CCL20—type 1 diabetes mellitus	0.00247	0.00794	CbGpPWpGaD
Gabapentin—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00241	0.00393	CcSEcCtD
Gabapentin—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00239	0.0039	CcSEcCtD
Gabapentin—Urticaria—Ramipril—type 1 diabetes mellitus	0.00232	0.00379	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—CHRM2—type 1 diabetes mellitus	0.00232	0.00747	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—INS—type 1 diabetes mellitus	0.00232	0.00746	CbGpPWpGaD
Gabapentin—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00231	0.00377	CcSEcCtD
Gabapentin—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00231	0.00377	CcSEcCtD
Gabapentin—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00215	0.00352	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00215	0.00693	CbGpPWpGaD
Gabapentin—Asthenia—Ramipril—type 1 diabetes mellitus	0.0021	0.00343	CcSEcCtD
Gabapentin—Pruritus—Ramipril—type 1 diabetes mellitus	0.00207	0.00338	CcSEcCtD
Gabapentin—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.002	0.00327	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00198	0.00639	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00196	0.00631	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00196	0.00631	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HBA2—type 1 diabetes mellitus	0.00195	0.00629	CbGpPWpGaD
Gabapentin—Dizziness—Ramipril—type 1 diabetes mellitus	0.00193	0.00316	CcSEcCtD
Gabapentin—Vomiting—Ramipril—type 1 diabetes mellitus	0.00186	0.00304	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00184	0.00594	CbGpPWpGaD
Gabapentin—Rash—Ramipril—type 1 diabetes mellitus	0.00184	0.00301	CcSEcCtD
Gabapentin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00184	0.00301	CcSEcCtD
Gabapentin—BCAT1—Metabolism—G6PC2—type 1 diabetes mellitus	0.00184	0.00592	CbGpPWpGaD
Gabapentin—Headache—Ramipril—type 1 diabetes mellitus	0.00183	0.00299	CcSEcCtD
Gabapentin—Nausea—Ramipril—type 1 diabetes mellitus	0.00174	0.00284	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.00171	0.00551	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ABCC8—type 1 diabetes mellitus	0.00159	0.00513	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00158	0.00509	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00151	0.00486	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00149	0.00481	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00149	0.00481	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00142	0.00457	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.0014	0.00452	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00136	0.00438	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00135	0.00436	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00126	0.00406	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HBA2—type 1 diabetes mellitus	0.00118	0.00381	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00118	0.0038	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00113	0.00364	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—G6PC2—type 1 diabetes mellitus	0.00111	0.00358	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.0011	0.00355	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	0.00109	0.00351	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ITPR3—type 1 diabetes mellitus	0.00106	0.00342	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	0.00106	0.00341	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00104	0.00333	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00103	0.00332	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00102	0.00329	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HBA1—type 1 diabetes mellitus	0.001	0.00322	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOC3—type 1 diabetes mellitus	0.000994	0.0032	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000976	0.00314	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000965	0.00311	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.000923	0.00297	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000876	0.00282	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00086	0.00277	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000853	0.00275	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000844	0.00272	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000793	0.00256	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GCG—type 1 diabetes mellitus	0.000778	0.00251	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000775	0.0025	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000766	0.00247	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000766	0.00247	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000763	0.00246	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000721	0.00232	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000712	0.00229	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000667	0.00215	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000666	0.00215	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CAT—type 1 diabetes mellitus	0.000659	0.00212	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000647	0.00208	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000644	0.00207	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HBA1—type 1 diabetes mellitus	0.000606	0.00195	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000605	0.00195	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOC3—type 1 diabetes mellitus	0.000602	0.00194	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000592	0.0019	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000585	0.00188	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000582	0.00188	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000531	0.00171	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000529	0.0017	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000521	0.00168	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000502	0.00162	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000487	0.00157	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000486	0.00157	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000473	0.00152	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GCG—type 1 diabetes mellitus	0.000471	0.00152	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000458	0.00147	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000456	0.00147	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000453	0.00146	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000453	0.00146	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000443	0.00143	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000441	0.00142	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—INS—type 1 diabetes mellitus	0.000437	0.00141	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000426	0.00137	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000424	0.00137	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALB—type 1 diabetes mellitus	0.000401	0.00129	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CAT—type 1 diabetes mellitus	0.000399	0.00128	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NOS3—type 1 diabetes mellitus	0.000383	0.00123	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000382	0.00123	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000377	0.00121	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000371	0.0012	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00036	0.00116	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000357	0.00115	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000357	0.00115	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000342	0.0011	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000337	0.00109	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000314	0.00101	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000312	0.00101	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00028	0.000901	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000269	0.000867	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—INS—type 1 diabetes mellitus	0.000265	0.000853	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000261	0.000842	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000261	0.00084	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALB—type 1 diabetes mellitus	0.000243	0.000782	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000238	0.000765	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000237	0.000762	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NOS3—type 1 diabetes mellitus	0.000232	0.000748	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000228	0.000734	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000218	0.000701	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000216	0.000697	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000206	0.000662	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000202	0.000651	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000199	0.000642	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000198	0.000637	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000166	0.000536	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000157	0.000506	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000152	0.00049	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000151	0.000487	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.00014	0.000452	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000138	0.000444	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000117	0.000377	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000117	0.000376	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000116	0.000374	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.83e-05	0.000317	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.94e-05	0.000288	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—type 1 diabetes mellitus	6.87e-05	0.000221	CbGpPWpGaD
